It should be a no-brainer to make sure that America’s investors don’t fund any of China’s military ambitions. And yet our very own Congressman, Patrick McHenry of North Carolina, is inexplicably blocking bipartisan congressional efforts to limit U.S. investments in China.
In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has
Americans are understandably worried about internet privacy. In particular, they fear their personal information could be hacked at any time. And if you ask them
Last year, more than 73,000 Americans died from an overdose of the synthetic opioid fentanyl. The drug itself is cheap and readily available, with thousands of pounds flowing into
Chinese solar manufacturers could take advantage of the Inflation Reduction Act’s tax credits by opening plants in the United States.
Removing trade barriers and reducing U.S. tariffs allowed China’s state-owned enterprises to flood the U.S. with deliberately underpriced goods.
As Congress returns to session, some call for new efforts to help struggling nations. Resuming the GSP, however, should not be one of them.
The Biden executive order simply doesn’t go far enough — or in a timely enough manner — to address China’s rapid growth in advanced technologies that pose both civilian and military challenges for the United States.
It is delusional to believe that a 21st century nation can achieve sustained economic growth and a thriving middle-class without manufacturing.
Unless Mexico immediately adheres to its 2019 steel obligations, the U.S. should reimpose Section 232 tariffs on Mexican steel imports.
